PlainPill

LGD-4033 vs MK-2866 for performance

Short answer: For performance, users rate them about the same: 90% report improvement with LGD-4033 (178 reports) and 88% with MK-2866 (192 reports).

LGD-4033 has 1 meta-analyses and 1 randomized trials on PubMed; MK-2866 has 0 and 0.

Based on 491 reports about LGD-4033 and 612 about MK-2866. Not medical advice.

LGD-4033
SARM
MK-2866
SARM
User score5433
Verdict
Mixed
Mixed
Positive
of reports that state an outcome
50%39%
Reports491612
ResearchBResearch: ModerateDResearch: None
Meta-analyses / RCTs1 / 10 / 0
Mainly used for
Weight loss
% reporting improvement
94% (33)89% (80)
Appetite
% reporting improvement
60% (5)62% (8)
Focus
% reporting improvement
50% (4)71% (7)
Energy
% reporting improvement
45% (22)54% (37)
Sleep
% reporting improvement
17% (6)20% (20)
Anxiety
% reporting improvement
0% (3)33% (9)
Mood
% reporting improvement
25% (24)63% (49)
Performance
% reporting improvement
90% (178)88% (192)
Recovery
% reporting improvement
100% (13)97% (60)
Pain & inflammation
% reporting improvement
0% (5)70% (27)
Digestion
% reporting improvement
50% (2)—
Libido
% reporting improvement
19% (27)31% (45)
Hormones
% reporting improvement
4% (48)4% (82)
Heart & lipids
% reporting improvement
0% (12)0% (8)
Skin & hair
% reporting improvement
0% (3)33% (6)
Common side effectssuppression, water retention, fatigue, stomach issuessuppression, fatigue, insomnia, headache
Typical dose reportedNot listedNot listed
LGD-4033
Latest review conclusion

SARMs have a positive effect on physical performance and body composition and are associated with moderate rates of mild to moderate adverse effects (AEs) and a low rate of severe AEs.

Clin Endocrinol (Oxf), 2025 ↗
What a user said
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
Full LGD-4033 profile →
MK-2866
What a user said
“I've taken LDG-4033 and Ostarine from Ceretropic and noticed slight psychoactive effects from both, immediately (within 30 minutes after dosing).”
Full MK-2866 profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate